HN2009003424A - (oxazolidinon-5-il-metil) -2-tiofen-carboxamidas sustituida y su uso en el campo de la coagulacion sanguinea - Google Patents
(oxazolidinon-5-il-metil) -2-tiofen-carboxamidas sustituida y su uso en el campo de la coagulacion sanguineaInfo
- Publication number
- HN2009003424A HN2009003424A HN2009003424A HN2009003424A HN2009003424A HN 2009003424 A HN2009003424 A HN 2009003424A HN 2009003424 A HN2009003424 A HN 2009003424A HN 2009003424 A HN2009003424 A HN 2009003424A HN 2009003424 A HN2009003424 A HN 2009003424A
- Authority
- HN
- Honduras
- Prior art keywords
- carboxamidas
- tiofen
- oxazolidinon
- sanguinea
- metil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
LA INVENCION SE REFIERE A NUEVAS OXAZOLIDINONAS SUSTITUIDAS, A PROCEDIMIENTOS PARA SU PREPARACION A SU USO PARA EL TRATAMIENTO Y/O PROFILAXIS DE ENFERMEDADES ASI COMO A SU USO PARA LA PREPARACION DE MEDICAMENTOS PARA EL TRATAMIENTO Y/O PROFILAXIS DE ENFERMEDADES DE FORMA PARTICULAR DE ENFERMEDADES TROMBOEMBOLICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007028319A DE102007028319A1 (de) | 2007-06-20 | 2007-06-20 | Substituierte Oxazolidinone und ihre Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2009003424A true HN2009003424A (es) | 2012-01-05 |
Family
ID=39731148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2009003424A HN2009003424A (es) | 2007-06-20 | 2009-12-15 | (oxazolidinon-5-il-metil) -2-tiofen-carboxamidas sustituida y su uso en el campo de la coagulacion sanguinea |
Country Status (43)
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006039589A1 (de) * | 2006-08-24 | 2008-03-06 | Bayer Healthcare Ag | Aminoacyl-Prodrugs II |
DE102007028407A1 (de) * | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE102007028319A1 (de) * | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE102010028362A1 (de) | 2010-04-29 | 2011-11-03 | Bayer Schering Pharma Aktiengesellschaft | Herstellverfahren |
CN102464658B (zh) * | 2010-11-03 | 2014-04-16 | 天津药物研究院 | 噁唑烷酮衍生物及其制备方法和用途 |
CA2824885A1 (en) | 2011-01-19 | 2012-07-26 | Bayer Intellectual Property Gmbh | Binding proteins to inhibitors of coagulation factors |
CN103626749A (zh) * | 2012-08-21 | 2014-03-12 | 苏州泽璟生物制药有限公司 | 取代的噁唑烷酮化合物和包含该化合物的药物组合物及其用途 |
CN103232446B (zh) * | 2013-05-17 | 2015-09-23 | 天津药物研究院 | 一种噁唑烷酮衍生物晶型ⅱ及其制备方法和用途 |
CN104163819A (zh) * | 2013-05-17 | 2014-11-26 | 天津药物研究院 | 一种噁唑烷酮衍生物的乙酸溶剂化物及其制备方法和用途 |
CN103242307B (zh) * | 2013-05-17 | 2015-08-12 | 天津药物研究院有限公司 | 一种噁唑烷酮类衍生物晶型ⅰ及其制备方法和用途 |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
DK149080C (da) | 1980-06-06 | 1986-07-28 | Sankyo Co | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
US5354772A (en) | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
DE4319041A1 (de) | 1992-10-23 | 1994-04-28 | Bayer Ag | Trisubstituierte Biphenyle |
ATE431347T1 (de) | 1996-10-14 | 2009-05-15 | Bayer Healthcare Ag | Neue heterocyclylmethyl-substituierte pyrazolderivate und ihre verwendung in der behandlung von herz-kreislauf-erkrankungen |
DE19642255A1 (de) | 1996-10-14 | 1998-04-16 | Bayer Ag | Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten |
DE19649460A1 (de) | 1996-11-26 | 1998-05-28 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
DE19834045A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | (4-Amino-5-ethylpyrimidin-2-yl)-1-(2-fluorbenzyl)-1H-pyrazolo[3,4-b]pyridin |
DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE19846514A1 (de) | 1998-10-09 | 2000-04-20 | Bayer Ag | Neue Heterocyclyl-methyl-substituierte Pyrazole |
US6259067B1 (en) | 1998-10-16 | 2001-07-10 | Medical Solutions, Inc. | Temperature control system and method for heating and maintaining medical items at desired temperatures |
DE19920352A1 (de) | 1999-05-04 | 2000-11-09 | Bayer Ag | Substituiertes Pyrazolderivat |
WO2000076971A2 (en) | 1999-06-14 | 2000-12-21 | Eli Lilly And Company | Serine protease inhibitors |
DE19942809A1 (de) | 1999-09-08 | 2001-03-15 | Bayer Ag | Verfahren zur Herstellung substituierter Pyrimidinderivate |
DE19943639A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften |
DE19943634A1 (de) | 1999-09-13 | 2001-04-12 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943636A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943635A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
AU782078B2 (en) * | 1999-12-21 | 2005-06-30 | Pharmacia & Upjohn Company | Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents |
DE19962924A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
GB0114004D0 (en) | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
GB0114005D0 (en) | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
TWI257389B (en) | 2001-06-12 | 2006-07-01 | Lilly Co Eli | Pharmaceutical compound |
DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
WO2003000657A1 (fr) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
JP2005520782A (ja) * | 2001-07-12 | 2005-07-14 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 向上した水溶解度を有するアミド含有化合物およびアミド含有化合物の水溶解度を向上させる方法 |
PL204263B1 (pl) | 2001-09-21 | 2009-12-31 | Bristol Myers Squibb Co | Pochodna 1H-pirazolo[3,4-c]pirydyny i jej zastosowanie oraz kompozycja farmaceutyczna i jej zastosowanie |
TW200738672A (en) | 2001-12-10 | 2007-10-16 | Bristol Myers Squibb Co | Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones |
PE20040804A1 (es) | 2002-12-19 | 2004-12-31 | Boehringer Ingelheim Pharma | DERIVADOS DE CARBOXAMIDAS COMO INHIBIDORES DEL FACTOR Xa |
US7205318B2 (en) | 2003-03-18 | 2007-04-17 | Bristol-Myers Squibb Company | Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors |
DE10322469A1 (de) | 2003-05-19 | 2004-12-16 | Bayer Healthcare Ag | Heterocyclische Verbindungen |
US7265140B2 (en) * | 2003-09-23 | 2007-09-04 | Pfizer Inc | Acyloxymethylcarbamate prodrugs of oxazolidinones |
US7547786B2 (en) | 2003-11-12 | 2009-06-16 | Daiichi Sankyo Company, Limited | Process for producing thiazole derivative |
DE10355461A1 (de) * | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
JP2005179272A (ja) | 2003-12-19 | 2005-07-07 | Yamanouchi Pharmaceut Co Ltd | カルボキサミド誘導体のマロン酸塩結晶 |
DE102004002044A1 (de) * | 2004-01-15 | 2005-08-04 | Bayer Healthcare Ag | Herstellverfahren |
GB0405272D0 (en) | 2004-03-09 | 2004-04-21 | Trigen Ltd | Compounds |
US7521470B2 (en) | 2004-06-18 | 2009-04-21 | Millennium Pharmaceuticals, Inc. | Factor Xa inhibitors |
US20060069260A1 (en) * | 2004-09-28 | 2006-03-30 | Huiping Zhang | Preparation of N-aryl pyridones |
DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
CA2602025A1 (en) | 2005-03-31 | 2006-10-12 | Mochida Pharmaceutical Co., Ltd. | Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
CN101218227A (zh) | 2005-07-08 | 2008-07-09 | 阿斯利康(瑞典)有限公司 | 作为因子Xa的抑制剂的杂环磺酰胺衍生物 |
AR057976A1 (es) * | 2005-08-29 | 2008-01-09 | Boehringer Ingelheim Int | Biarilos sustituidos y su uso como medicamentos. |
DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
DE102005050376A1 (de) | 2005-10-21 | 2007-05-31 | Bayer Healthcare Ag | Dicarbonsäure-Derivate und ihre Verwendung |
DE102005050377A1 (de) | 2005-10-21 | 2007-04-26 | Bayer Healthcare Ag | Heterocyclische Verbindungen und ihre Verwendung |
DE102005050498A1 (de) | 2005-10-21 | 2007-06-06 | Bayer Healthcare Aktiengesellschaft | Cyclopropylessigsäure-Derivate und ihre Verwendung |
DE102005050375A1 (de) | 2005-10-21 | 2007-04-26 | Bayer Healthcare Ag | Tetrazol-Derivate und ihre Verwendung |
DE102005050497A1 (de) | 2005-10-21 | 2007-04-26 | Bayer Healthcare Ag | Difluorphenol-Derivate und ihre Verwendung |
DE102006025314A1 (de) * | 2006-05-31 | 2007-12-06 | Bayer Healthcare Ag | Arylsubstituierte Heterozyklen und ihre Verwendung |
DE102006039589A1 (de) * | 2006-08-24 | 2008-03-06 | Bayer Healthcare Ag | Aminoacyl-Prodrugs II |
DE102007028407A1 (de) * | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE102007028319A1 (de) * | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE102007028406A1 (de) * | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
-
2007
- 2007-06-20 DE DE102007028319A patent/DE102007028319A1/de not_active Withdrawn
-
2008
- 2008-06-06 UY UY31133A patent/UY31133A1/es not_active Application Discontinuation
- 2008-06-07 EP EP08773372A patent/EP2170877B1/de active Active
- 2008-06-07 JP JP2010512559A patent/JP5537421B2/ja not_active Expired - Fee Related
- 2008-06-07 CA CA2692166A patent/CA2692166C/en not_active Expired - Fee Related
- 2008-06-07 AU AU2008266525A patent/AU2008266525B8/en not_active Ceased
- 2008-06-07 ES ES08773372T patent/ES2397799T3/es active Active
- 2008-06-07 SI SI200830882T patent/SI2170877T1/sl unknown
- 2008-06-07 PT PT87733721T patent/PT2170877E/pt unknown
- 2008-06-07 MX MX2009013711A patent/MX2009013711A/es active IP Right Grant
- 2008-06-07 US US12/665,729 patent/US8383822B2/en not_active Expired - Fee Related
- 2008-06-07 CN CN2008801031298A patent/CN101821259B/zh not_active Expired - Fee Related
- 2008-06-07 RU RU2010101307/04A patent/RU2481345C2/ru not_active IP Right Cessation
- 2008-06-07 PL PL08773372T patent/PL2170877T3/pl unknown
- 2008-06-07 BR BRPI0813736-6A2A patent/BRPI0813736A2/pt not_active Application Discontinuation
- 2008-06-07 KR KR1020097026556A patent/KR101535312B1/ko not_active IP Right Cessation
- 2008-06-07 DK DK08773372.1T patent/DK2170877T5/da active
- 2008-06-07 RS RS20130039A patent/RS52639B/en unknown
- 2008-06-07 UA UAA201000550A patent/UA98793C2/ru unknown
- 2008-06-07 WO PCT/EP2008/004562 patent/WO2008155032A1/de active Application Filing
- 2008-06-07 SG SG2012045779A patent/SG182220A1/en unknown
- 2008-06-07 MY MYPI20095462 patent/MY150931A/en unknown
- 2008-06-07 NZ NZ581540A patent/NZ581540A/en not_active IP Right Cessation
- 2008-06-09 CL CL2008001691A patent/CL2008001691A1/es unknown
- 2008-06-10 PE PE2008000978A patent/PE20090332A1/es not_active Application Discontinuation
- 2008-06-11 PA PA20088784301A patent/PA8784301A1/es unknown
- 2008-06-12 AR ARP080102515A patent/AR066981A1/es not_active Application Discontinuation
- 2008-06-17 JO JO2008282A patent/JO2798B1/en active
- 2008-06-19 AR ARP080102607A patent/AR067057A1/es not_active Application Discontinuation
- 2008-06-19 TW TW097122783A patent/TWI413642B/zh not_active IP Right Cessation
-
2009
- 2009-11-26 IL IL202351A patent/IL202351A/en not_active IP Right Cessation
- 2009-11-30 TN TNP2009000503A patent/TN2009000503A1/fr unknown
- 2009-12-15 SV SV2009003435A patent/SV2009003435A/es unknown
- 2009-12-15 HN HN2009003424A patent/HN2009003424A/es unknown
- 2009-12-15 DO DO2009000285A patent/DOP2009000285A/es unknown
- 2009-12-15 CR CR11168A patent/CR11168A/es not_active Application Discontinuation
- 2009-12-15 GT GT200900319A patent/GT200900319A/es unknown
- 2009-12-15 CU CU20090216A patent/CU23820A3/es active IP Right Grant
- 2009-12-15 EC EC2009009807A patent/ECSP099807A/es unknown
- 2009-12-16 CO CO09144220A patent/CO6251281A2/es active IP Right Grant
-
2010
- 2010-01-19 MA MA32539A patent/MA31535B1/fr unknown
-
2011
- 2011-02-22 HK HK11101717.7A patent/HK1147991A1/xx not_active IP Right Cessation
-
2013
- 2013-01-28 HR HRP20130072AT patent/HRP20130072T1/hr unknown
- 2013-02-01 CY CY20131100095T patent/CY1113580T1/el unknown
- 2013-02-19 US US13/770,270 patent/US8846934B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HN2009003424A (es) | (oxazolidinon-5-il-metil) -2-tiofen-carboxamidas sustituida y su uso en el campo de la coagulacion sanguinea | |
PA8784101A1 (es) | Oxazolidinonas sustituidas y su uso | |
GT200900230A (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso | |
PA8772101A1 (es) | Imidazol-triazolopirimidinas sustituidas | |
DOP2007000102A (es) | Arilimidazolonas y ariltriazolona sustituidas asi como su uso | |
DOP2012000299A (es) | 5-fluoro-1h-pirazolopiridinas sustituidas y su uso | |
GT200900095A (es) | Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas. | |
CR11472A (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso | |
UY31228A1 (es) | Ariloxazoles sustituidos y su uso | |
CO6440531A2 (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
UY32882A (es) | (heteroarilmetil) tiohidantoínas sustituidas | |
CL2009000402A1 (es) | Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras. | |
CR20120040A (es) | Derivados de 17-hidroxi-17-pentafluoroetil-estra-4,9(10)-dien-11-arilo, procedimientos para su preparación y su uso para el tratamiento de enfermedades | |
DOP2006000280A (es) | Nuevos derivados de furopirimidina acíclicos sustituidos y su uso | |
PA8806501A1 (es) | Triazolotriazinas y triazolopirazinas y su uso | |
HN2011003102A (es) | Piperidinas sustituidas | |
CL2010001577A1 (es) | Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias. | |
UY29247A1 (es) | Amidas de ácido pirazindicarboxílico y su uso | |
CR10449A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inihibidores de receptores de vasopresina | |
HN2010001125A (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso |